rivastigmine Oral Capsule

Brand(s)
Exelon
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Novartis Pharmaceuticals Corporation (2015-02-03)
Oldest Current Product
2000-04-30
License(s)
NDA, NDA AUTHORIZED GENERIC, ANDA
RxNORM
ORAL CAPSULE\RIVASTIGMINE
FDAOB
ORAL\CAPSULE\RIVASTIGMINE TARTRATE
SPL Active
ORAL\CAPSULE\RIVASTIGMINE TARTRATE
SPL Moiety
ORAL\CAPSULE\RIVASTIGMINE

product(s) by strength(s)

rivastigmine 1.5 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000780323ExelonNDANovartis Pharmaceuticals Corporation2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA020823f1e28b44-3897-4788-9659-f5d6bce4d91e

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1005913208ANDAWatson Laboratories, Inc.2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA07712936b4f524-90e6-415c-8c0c-8983da2c7fd4
2007812614NDA AUTHORIZED GENERICSandoz Inc2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA0208234e775022-4b71-4716-bc9b-f374edaf9edb
3333420089ANDAMacleods Pharmaceuticals Limited2014-09-02RIVASTIGMINE TARTRATEORALCAPSULEANDA2031484364f6ef-a8da-4805-be0d-aabbe8ca2d21
4467080063ANDAAlembic Limited2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA09168933e6a772-382d-45f5-9d45-966c07759367
5519910793ANDABreckenridge Pharmaceutical, Inc.2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA091689d4eda27a-0c99-48a2-a973-03c5267634da
6551110352ANDADr. Reddy'S Laboratories Ltd2011-09-01RIVASTIGMINE TARTRATEORALCAPSULEANDA0771300e20124c-725a-0145-996c-2ff908703162
7605053220ANDAApotex Corp2013-02-20RIVASTIGMINE TARTRATEORALCAPSULEANDA091072ca943349-53ea-2b6e-53c3-0265b1a81f8a
8627560145ANDASun Pharmaceutical Industries Limited2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA077131bac9ca81-db70-41aa-82af-6c5bb8496846

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1548684512ExelonNDAPhysicians Total Care, Inc.2002-04-12RIVASTIGMINE TARTRATEORALCAPSULE000780323NDA020823fead084a-a376-4d57-bdf0-aa7ed3655505
2604290393ANDAGolden State Medical Supply, Inc.2015-03-10RIVASTIGMINE TARTRATEORALCAPSULE605053220ANDA0910727d97556a-d954-434e-9a95-e22dc869a229
3637390576ANDAMckesson Packaging Services A Business Unit Of Mckesson Corporation2013-03-01RIVASTIGMINE TARTRATEORALCAPSULE005913208ANDA0771298dc97a13-c5eb-4421-ae86-7e0877186e2d
4680840550ANDAAmerican Health Packaging2012-01-06RIVASTIGMINE TARTRATEORALCAPSULE627560145ANDA077131d2690b7a-94d7-42f9-acb5-9556f70fe364
5681514134ANDACarilion Materials Management2010-07-01RIVASTIGMINE TARTRATEORALCAPSULE627560145ANDA0771316bddaf00-fb85-49e7-9aed-bc5efdfc4311

rivastigmine 3 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000780324ExelonNDANovartis Pharmaceuticals Corporation2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA020823f1e28b44-3897-4788-9659-f5d6bce4d91e

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1005913209ANDAWatson Laboratories, Inc.2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA07712936b4f524-90e6-415c-8c0c-8983da2c7fd4
2007812615NDA AUTHORIZED GENERICSandoz Inc2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA0208234e775022-4b71-4716-bc9b-f374edaf9edb
3333420090ANDAMacleods Pharmaceuticals Limited2014-09-02RIVASTIGMINE TARTRATEORALCAPSULEANDA2031484364f6ef-a8da-4805-be0d-aabbe8ca2d21
4467080064ANDAAlembic Limited2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA09168933e6a772-382d-45f5-9d45-966c07759367
5519910794ANDABreckenridge Pharmaceutical, Inc.2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA091689d4eda27a-0c99-48a2-a973-03c5267634da
6551110353ANDADr. Reddy'S Laboratories Ltd2011-09-01RIVASTIGMINE TARTRATEORALCAPSULEANDA0771300e20124c-725a-0145-996c-2ff908703162
7605053221ANDAApotex Corp2013-02-20RIVASTIGMINE TARTRATEORALCAPSULEANDA091072ca943349-53ea-2b6e-53c3-0265b1a81f8a
8627560146ANDASun Pharmaceutical Industries Limited2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA077131bac9ca81-db70-41aa-82af-6c5bb8496846

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1548685839ExelonNDAPhysicians Total Care, Inc.2007-12-04RIVASTIGMINE TARTRATEORALCAPSULE000780324NDA020823fead084a-a376-4d57-bdf0-aa7ed3655505
2604290394ANDAGolden State Medical Supply, Inc.2015-03-10RIVASTIGMINE TARTRATEORALCAPSULE605053221ANDA0910727d97556a-d954-434e-9a95-e22dc869a229
3637390577ANDAMckesson Packaging Services A Business Unit Of Mckesson Corporation2013-02-01RIVASTIGMINE TARTRATEORALCAPSULE005913209ANDA0771298dc97a13-c5eb-4421-ae86-7e0877186e2d

rivastigmine 4.5 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000780325ExelonNDANovartis Pharmaceuticals Corporation2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA020823f1e28b44-3897-4788-9659-f5d6bce4d91e

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1005913210ANDAWatson Laboratories, Inc.2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA07712936b4f524-90e6-415c-8c0c-8983da2c7fd4
2007812616NDA AUTHORIZED GENERICSandoz Inc2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA0208234e775022-4b71-4716-bc9b-f374edaf9edb
3333420091ANDAMacleods Pharmaceuticals Limited2014-09-02RIVASTIGMINE TARTRATEORALCAPSULEANDA2031484364f6ef-a8da-4805-be0d-aabbe8ca2d21
4467080065ANDAAlembic Limited2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA09168933e6a772-382d-45f5-9d45-966c07759367
5519910795ANDABreckenridge Pharmaceutical, Inc.2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA091689d4eda27a-0c99-48a2-a973-03c5267634da
6551110354ANDADr. Reddy'S Laboratories Ltd2011-09-01RIVASTIGMINE TARTRATEORALCAPSULEANDA0771300e20124c-725a-0145-996c-2ff908703162
7605053222ANDAApotex Corp2013-02-20RIVASTIGMINE TARTRATEORALCAPSULEANDA091072ca943349-53ea-2b6e-53c3-0265b1a81f8a
8627560147ANDASun Pharmaceutical Industries Limited2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA077131bac9ca81-db70-41aa-82af-6c5bb8496846

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1548685240ExelonNDAPhysicians Total Care, Inc.2005-03-03RIVASTIGMINE TARTRATEORALCAPSULE000780325NDA020823fead084a-a376-4d57-bdf0-aa7ed3655505
2604290395ANDAGolden State Medical Supply, Inc.2015-03-10RIVASTIGMINE TARTRATEORALCAPSULE605053222ANDA0910727d97556a-d954-434e-9a95-e22dc869a229
3637390578ANDAMckesson Packaging Services A Business Unit Of Mckesson Corporation2013-03-01RIVASTIGMINE TARTRATEORALCAPSULE005913210ANDA0771298dc97a13-c5eb-4421-ae86-7e0877186e2d

rivastigmine 6 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000780326ExelonNDANovartis Pharmaceuticals Corporation2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA020823f1e28b44-3897-4788-9659-f5d6bce4d91e

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1005913211ANDAWatson Laboratories, Inc.2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA07712936b4f524-90e6-415c-8c0c-8983da2c7fd4
2007812617NDA AUTHORIZED GENERICSandoz Inc2000-04-30RIVASTIGMINE TARTRATEORALCAPSULENDA0208234e775022-4b71-4716-bc9b-f374edaf9edb
3333420092ANDAMacleods Pharmaceuticals Limited2014-09-02RIVASTIGMINE TARTRATEORALCAPSULEANDA2031484364f6ef-a8da-4805-be0d-aabbe8ca2d21
4467080066ANDAAlembic Limited2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA09168933e6a772-382d-45f5-9d45-966c07759367
5519910796ANDABreckenridge Pharmaceutical, Inc.2012-06-13RIVASTIGMINE TARTRATEORALCAPSULEANDA091689d4eda27a-0c99-48a2-a973-03c5267634da
6551110355ANDADr. Reddy'S Laboratories Ltd2011-09-01RIVASTIGMINE TARTRATEORALCAPSULEANDA0771300e20124c-725a-0145-996c-2ff908703162
7605053223ANDAApotex Corp2013-02-20RIVASTIGMINE TARTRATEORALCAPSULEANDA091072ca943349-53ea-2b6e-53c3-0265b1a81f8a
8627560148ANDASun Pharmaceutical Industries Limited2010-07-01RIVASTIGMINE TARTRATEORALCAPSULEANDA077131bac9ca81-db70-41aa-82af-6c5bb8496846

relabeler product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formequivalent productapplicationspl
1548685339ExelonNDAPhysicians Total Care, Inc.2005-06-17RIVASTIGMINE TARTRATEORALCAPSULE000780326NDA020823fead084a-a376-4d57-bdf0-aa7ed3655505
2548686145ANDAPhysicians Total Care, Inc.2010-09-15RIVASTIGMINE TARTRATEORALCAPSULE62756014886ANDA077131719ef928-c061-49d3-83d3-6e7482462679
3604290396ANDAGolden State Medical Supply, Inc.2015-03-10RIVASTIGMINE TARTRATEORALCAPSULE605053223ANDA0910727d97556a-d954-434e-9a95-e22dc869a229
4637390579ANDAMckesson Packaging Services A Business Unit Of Mckesson Corporation2013-03-01RIVASTIGMINE TARTRATEORALCAPSULE005913211ANDA0771298dc97a13-c5eb-4421-ae86-7e0877186e2d

application(s)

#idtitleapplicantapprovedapproved drug
1ANDA077129RIVASTIGMINE TARTRATEWATSON LABORATORIES INC2008-01-08ANDA077129_001, ANDA077129_002, ANDA077129_003, ANDA077129_004
2ANDA077130RIVASTIGMINE TARTRATEDR REDDYS LABORATORIES INC2007-10-31ANDA077130_001, ANDA077130_002, ANDA077130_003, ANDA077130_004
3ANDA077131RIVASTIGMINE TARTRATESUN PHARMACEUTICAL INDUSTRIES INC2007-10-22ANDA077131_001, ANDA077131_002, ANDA077131_003, ANDA077131_004
4ANDA090879RIVASTIGMINE TARTRATEORCHID HEALTHCARE2015-06-10ANDA090879_001, ANDA090879_002, ANDA090879_003, ANDA090879_004
5ANDA091072RIVASTIGMINE TARTRATEAPOTEX INC2013-05-16ANDA091072_001, ANDA091072_002, ANDA091072_003, ANDA091072_004
6ANDA091689RIVASTIGMINE TARTRATEALEMBIC PHARMACEUTICALS LTD2012-06-12ANDA091689_001, ANDA091689_002, ANDA091689_003, ANDA091689_004
7ANDA203148RIVASTIGMINE TARTRATEMACLEODS PHARMACEUTICALS LTD2014-08-22ANDA203148_001, ANDA203148_002, ANDA203148_003, ANDA203148_004
8NDA020823EXELONNOVARTIS PHARMACEUTICALS CORP2000-04-21NDA020823_003, NDA020823_004, NDA020823_005, NDA020823_006

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldTEapprovedapplication
1ANDA077129_001RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULEFalseAB2008-01-08RIVASTIGMINE TARTRATE
2ANDA077129_002RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2008-01-08RIVASTIGMINE TARTRATE
3ANDA077129_003RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2008-01-08RIVASTIGMINE TARTRATE
4ANDA077129_004RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2008-01-08RIVASTIGMINE TARTRATE
5ANDA077130_001RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULEFalseAB2007-10-31RIVASTIGMINE TARTRATE
6ANDA077130_002RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2007-10-31RIVASTIGMINE TARTRATE
7ANDA077130_003RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2007-10-31RIVASTIGMINE TARTRATE
8ANDA077130_004RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2007-10-31RIVASTIGMINE TARTRATE
9ANDA077131_001RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULEFalseAB2007-10-22RIVASTIGMINE TARTRATE
10ANDA077131_002RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2007-10-22RIVASTIGMINE TARTRATE
11ANDA077131_003RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2007-10-22RIVASTIGMINE TARTRATE
12ANDA077131_004RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2007-10-22RIVASTIGMINE TARTRATE
13ANDA090879_001RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULEFalseAB2015-06-10RIVASTIGMINE TARTRATE
14ANDA090879_002RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2015-06-10RIVASTIGMINE TARTRATE
15ANDA090879_003RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2015-06-10RIVASTIGMINE TARTRATE
16ANDA090879_004RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2015-06-10RIVASTIGMINE TARTRATE
17ANDA091072_001RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULEFalseAB2013-05-16RIVASTIGMINE TARTRATE
18ANDA091072_002RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2013-05-16RIVASTIGMINE TARTRATE
19ANDA091072_003RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2013-05-16RIVASTIGMINE TARTRATE
20ANDA091072_004RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2013-05-16RIVASTIGMINE TARTRATE
21ANDA091689_001RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULEFalseAB2012-06-12RIVASTIGMINE TARTRATE
22ANDA091689_002RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2012-06-12RIVASTIGMINE TARTRATE
23ANDA091689_003RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2012-06-12RIVASTIGMINE TARTRATE
24ANDA091689_004RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2012-06-12RIVASTIGMINE TARTRATE
25ANDA203148_001RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULEFalseAB2014-08-22RIVASTIGMINE TARTRATE
26ANDA203148_002RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2014-08-22RIVASTIGMINE TARTRATE
27ANDA203148_003RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2014-08-22RIVASTIGMINE TARTRATE
28ANDA203148_004RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2014-08-22RIVASTIGMINE TARTRATE
29NDA020823_003RXRIVASTIGMINE TARTRATE (EQ 1.5MG BASE)ORALCAPSULETrueAB2000-04-21EXELON
30NDA020823_004RXRIVASTIGMINE TARTRATE (EQ 3MG BASE)ORALCAPSULEFalseAB2000-04-21EXELON
31NDA020823_005RXRIVASTIGMINE TARTRATE (EQ 4.5MG BASE)ORALCAPSULEFalseAB2000-04-21EXELON
32NDA020823_006RXRIVASTIGMINE TARTRATE (EQ 6MG BASE)ORALCAPSULEFalseAB2000-04-21EXELON

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)in other drug docs
10e20124c-725a-0145-996c-2ff908703162 (view SPL)These highlights do not include all the information needed to use rivastigmine tartrate safely and effectively. See full prescribing information for rivastigmine tartrate. RIVASTIGMINE tartrate capsules USP, for oral use Initial U.S. Approval: 2000prescriptionHuman PrescriptionDr. Reddy'S Laboratories Ltdanalysis, manufacture2015-03-126551110352, 551110353, 551110354, 551110355
233e6a772-382d-45f5-9d45-966c07759367 (view SPL)These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Rivastigmine Tartrate Capsules USP, for oral use.Initial U.S. Approval: 2000prescriptionHuman PrescriptionAlembic LimitedMANUFACTURE2015-01-081467080063, 467080064, 467080065, 467080066
336b4f524-90e6-415c-8c0c-8983da2c7fd4 (view SPL)Rivastigmine Tartrate Capsules Issued: October 2007prescriptionHuman PrescriptionWatson Laboratories, Inc.2010-07-027005913208, 005913209, 005913210, 005913211
44364f6ef-a8da-4805-be0d-aabbe8ca2d21 (view SPL)These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP.RIVASTIGMINE TARTRATE CAPSULES USP, for oral use Initial U.S. Approval: 2000prescriptionHuman PrescriptionMacleods Pharmaceuticals LimitedANALYSIS, LABEL, MANUFACTURE, PACK2014-09-021333420089, 333420090, 333420091, 333420092
54e775022-4b71-4716-bc9b-f374edaf9edb (view SPL)These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules. Rivastigmine Tartrate Capsules, for oral use Initial U.S. Approval: 2000prescriptionHuman PrescriptionSandoz Inc2013-10-012007812614, 007812615, 007812616, 007812617
66bddaf00-fb85-49e7-9aed-bc5efdfc4311 (view SPL)Rivastigmine Tartrate CapsulesprescriptionHuman PrescriptionCarilion Materials ManagementREPACK2010-06-283681514134
7719ef928-c061-49d3-83d3-6e7482462679 (view SPL)Rivastigmine Tartrate CapsulesprescriptionHuman PrescriptionPhysicians Total Care, Inc.relabel2010-06-281548686145
87d97556a-d954-434e-9a95-e22dc869a229 (view SPL)These highlights do not include all the information needed to use RIVASTIGMINE tartrate capsules safely and effectively. See full prescribing information for RIVASTIGMINE tartrate capsules.RIVASTIGMINE TARTRATE, USP capsules, for oral useInitial U.S. Approval: 2000prescriptionHuman PrescriptionGolden State Medical Supply, Inc.RELABEL, REPACK2015-07-011604290393, 604290394, 604290395, 604290396
98dc97a13-c5eb-4421-ae86-7e0877186e2d (view SPL)Rivastigmine Tartrate CapsulesprescriptionHuman PrescriptionMckesson Packaging Services A Business Unit Of Mckesson CorporationREPACK2013-02-251637390576, 637390577, 637390578, 637390579
10bac9ca81-db70-41aa-82af-6c5bb8496846 (view SPL)These highlights do not include all the information needed to use rivastigmine tartrate capsules safely and effectively. See full prescribing information for rivastigmine tartrate capsules. RIVASTIGMINE tartrate capsules, for oral useInitial U.S. Approval: 2000prescriptionHuman PrescriptionSun Pharmaceutical Industries LimitedANALYSIS, MANUFACTURE2015-05-225627560145, 627560146, 627560147, 627560148
11ca943349-53ea-2b6e-53c3-0265b1a81f8a (view SPL)These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES, USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES, USP. RIVASTIGMINE TARTRATE capsules , for oral use Initial U.S. Approval: 2000prescriptionHuman PrescriptionApotex Corpanalysis, manufacture2015-08-318605053220, 605053221, 605053222, 605053223
12d2690b7a-94d7-42f9-acb5-9556f70fe364 (view SPL)Rivastigmine Tartrate Capsules 8255001/0213 Rx onlyprescriptionHuman PrescriptionAmerican Health PackagingREPACK2015-02-102680840550
13d4eda27a-0c99-48a2-a973-03c5267634da (view SPL)These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP . RIVASTIGMINE TARTRATE Capsules USP, for oral use Initial U.S. Approval: 2000prescriptionHuman PrescriptionBreckenridge Pharmaceutical, Inc.MANUFACTURE2015-04-286519910793, 519910794, 519910795, 519910796
14f1e28b44-3897-4788-9659-f5d6bce4d91e (view SPL)These highlights do not include all the information needed to use EXELON safely and effectively. See full prescribing information for EXELON. EXELON (rivastigmine tartrate) capsules, for oral use EXELON (rivastigmine tartrate) oral solution Initial U.S. Approval: 2000prescriptionHuman PrescriptionNovartis Pharmaceuticals Corporation2015-02-0314000780323, 000780324, 000780325, 000780326, 000780339rivastigmine Oral Solution
15fead084a-a376-4d57-bdf0-aa7ed3655505 (view SPL)prescriptionHuman PrescriptionPhysicians Total Care, Inc.relabel, repack2010-06-091548684512, 548685240, 548685339, 548685839

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII